BiondVax Pharmaceuticals Ltd ADR (BVXV)

$ 1.465.04%

Price Chart

Key Statistics

Market Cap

$ 4.97M

P/E Ratio

0.00

Revenue (TTM)

$ 0

Volume

57.34K

52W High

$ 0.00

52W Low

$ 0.00

Dividend Yield

0.00%

Beta

2.37

Technicals

50-Day MA

1.1663

200-Day MA

1.7912

52 Week High

N/A

52 Week Low

N/A

About BVXV

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and auto.

Employees

Headquarters

Jerusalem, Israel

CEO

Mr. Amir Reichman M.B.A., M.Sc.

Latest News

BVXV: Developing anti-IL-17 NanoAb - Yahoo Finance

2023-05-30 • Google News

BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate - BioSpace

2020-10-23 • Google News

Press Release dated September 6, 2023, “BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological Therapeutics.” - SEC.gov

2023-09-06 • Google News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name

LTP

% Chg

KWE

KWESST Micro System...

$ 5.81

2576.19

OMEX

Odyssey Marine Expl...

$ 0.76

78.14

UPXI

Upexi Inc. Common S...

$ 13.20

22.22

NOW

ServiceNow Inc. Com...

$ 946.00

16.21

FIX

Comfort Systems USA...

$ 411.56

15.80

Top Losers

Symbol/Name

LTP

% Chg

CSGP

CoStar Group Inc. C...

$ 71.44

-12.71

ASGN

ASGN Incorporated C...

$ 51.59

-11.81

ALK

Alaska Air Group In...

$ 41.75

-9.61

IBM

International Busin...

$ 229.35

-6.47

NVAX

Novavax Inc. Common...

$ 6.98

-6.31